Document Detail


Antioxidant therapy for the treatment of pulmonary hypertension.
MedLine Citation:
PMID:  23330936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Substantial experimental evidence suggests the usefulness of antioxidants for the treatment of various forms of pulmonary hypertension. However, no recommendations have yet been made if patients with pulmonary hypertension should receive pharmacologic and/or dietary antioxidants. Our understanding of antioxidants has evolved greatly over the last two decades, from the primitive use of natural antioxidant vitamins to the modulation of vascular oxidases, such as NAD(P)H oxidases. These oxidases and their products not only regulate pulmonary vascular tone and intimal and smooth muscle thickening, but also modulate the adaptation of the right ventricle to increased afterload. It is important that well-designed randomized clinical trials be conducted to test the importance of oxidase-reactive oxygen species activation in the pathogenesis and treatment of pulmonary hypertension. The purpose of this Forum on Pulmonary Hypertension is to summarize the available preclinical information, which may aid in designing and conducting future randomized clinical trials for evaluating the efficacy of antioxidants for the treatment of pulmonary hypertension. The complexity of oxidative pathways contributed to the tremendous difficulties and challenges in selecting agents, doses, and designing clinical trials. Further studies using human, animal, and cell culture models may be needed to define optimal trials. This Forum on Pulmonary Hypertension should stimulate new thinking and provide essential background information to better define the challenges of developing successful randomized clinical trials in the near future.
Authors:
Yuichiro J Suzuki; Robin H Steinhorn; Mark T Gladwin
Related Documents :
15108016 - Interventional radiology in carney triad.
577606 - Rapid prediction of pulmonary maturity by amniotic fluid lipid globule formation.
24089266 - Genetic impact dominates over environmental effects in development of carotid artery st...
23729596 - Heart valve engineering: decellularized allograft matrices in clinical practice.
409246 - Computed angiotomography.
20045616 - Successful repair of a ruptured stanford type b aortic dissection during pregnancy.
Publication Detail:
Type:  Editorial; Introductory Journal Article     Date:  2013-02-28
Journal Detail:
Title:  Antioxidants & redox signaling     Volume:  18     ISSN:  1557-7716     ISO Abbreviation:  Antioxid. Redox Signal.     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-05     Completed Date:  2013-10-22     Revised Date:  2014-05-13    
Medline Journal Info:
Nlm Unique ID:  100888899     Medline TA:  Antioxid Redox Signal     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1723-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antioxidants / therapeutic use*
Humans
Hypertension, Pulmonary / drug therapy*,  metabolism
Chemical
Reg. No./Substance:
0/Antioxidants
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mechanisms of retroviral integration and mutagenesis.
Next Document:  Quitting Drugs: Quantitative and Qualitative Features.